randomized controlled trial

(redirected from Triple-blind)

ran·dom·i·zed con·trolled tri·al (RCT),

an epidemiologic experiment in which subjects in a population are allocated randomly into groups, called "experimental" or "study" and "control" groups to receive or not receive an experimental therapeutic or preventive regimen, procedure, maneuver, or intervention.

ran·dom·i·zed con·trolled tri·al

(RCT) (ran'dŏm-īzd kŏn-trōld trī'ăl)
A type of experiment that randomly assigns subjects to various interventions, including a control group, in order to minimize the risk of bias.
See also: control group

randomized controlled trial

Abbreviation: RCT
An experimental study to assess the effects of a particular variable, e.g., a drug or treatment, in which subjects are assigned randomly to an experimental, placebo, or control group. The experimental group receives the drug or procedure; the placebo group's medication is disguised to resemble the drug being investigated. The control group receives nothing. Members of each group are prevented from knowing whether they are receiving active therapy. The researchers gathering the data are also typically blinded to group assignment.


Although RCTs are an essential element in proving clinical relationships (such as between the use of a new drug and the safe cure of a disease), most RCTs do not enroll enough patients for a long enough time to detect rare events.
See also: trial

trial, randomized controlled (RCT) 

An experimental design used for testing the effectiveness of a new medication or a new therapeutic procedure. Individuals are assigned randomly to a treatment group (experimental therapy) and a control group (placebo or standard therapy) and the outcomes are compared. The trial is strengthened by 'blinding' or masking (single-blind, double-blind or triple-blind study) and cross-over design. RCT is the most accepted scientific method of determining the benefit of a drug or a therapeutic procedure. It represents the best evidence available, which is integrated into the final decision about the management of a condition by healthcare practitioners in what is called evidence-based healthcare. Syn. randomized clinical trial. See sampling; significance; study.
References in periodicals archive ?
In a triple-blind, placebo-controlled, randomized, pre- and post-intervention assessment design, 20 healthy participants without current mood disorder received a 4-week probiotic food-supplement intervention with the multispecies probiotics, while 20 control participants received an inert placebo for the same period.
silymarin) extract supplementation on antioxidant status and hs-CRP in patients with type 2 diabetes mellitus: A randomised, triple-blind, placebo-controlled clinical trial.
Belief can be so strong that pharmaceutical companies use double- and triple-blind randomized studies to try to exclude the power of the mind over the body when evaluating new drugs.
A randomised, controlled, triple-blind trial of the efficacy of homeopathic treatment for chronic fatigue syndrome.
2002) and triple-blind (Beischel & Schwartz, 2007) mediumship investigations.
There's a triple-blind study going on now with newly menopausal women using natural progesterone cream and a placebo.
Officials at the CDC and the Joint United Nations Program on HIV/AIDS (UNAIDS) plan to spend the next few months reviewing public health recommendations on the use of nonoxynol-9 as a result of preliminary findings from a triple-blind study released at the 13th International AIDS Conference in Durban, South Africa, in July
Judged against other national soymilk products, 8th Continent Complete was selected as the winning product in the soymilk category for its superior taste in a triple-blind taste test.
Acute Effect of Topical Menthol on Chronic Pain in Slaughterhouse Workers with Carpal Tunnel Syndrome: Triple-Blind, Randomized Placebo-Controlled Trail.
A randomised, controlled, triple-blind trial of the efficacy of homoeopathic treatment for chronic fatigue syndrome.
Preliminary results of the triple-blind nonoxynol-9 study, unveiled at the 13th International AIDS Conference in Durban, South Africa, involved 990 prostitutes in four African and two Asian cities where HIV rates are high.
The judging was conducted by a panel of Masters of Taste executive chefs in a triple-blind taste test in Northern California.